跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
POLYSPORIN SINGLES - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
POLYSPORIN SINGLES
Authorized
STANDARD
POLYSPORIN SINGLES
johnson & johnson inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
1a145babc7b6bbba
Company
johnson & johnson inc
Type
Standard
Approval Details
Approval Id
1a145babc7b6bbba
Drug Approval Canada Name
POLYSPORIN SINGLES
Product Name
POLYSPORIN SINGLES
Status
Cancelled Post Market
Status Date
2023-12-08
Original Market Date
2019-10-28
Din
02481618
Drug Class
Human
Dosage Form
Ointment
Route Of Administration
Topical
Schedule
OTC
Ahfs
84:04.04
Atc Original
D06AX30 COMBINATIONS OF ANTIBIOTICS
Atc Name
d 06 ax 30
Aig Number
0231324002
Company Name
johnson & johnson inc
Company Address
88 Mcnabb Street, Markham, Ontario, Canada, L3R 5L2
Active Ingredients
BACITRACIN ZINC
500 UNIT / G
POLYMYXIN B SULFATE
10000 UNIT / G
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
1a145babc7b6bbba
Type
Standard
Back to Health Canada Approvals